Treating Relapsed Refractory Acute Myeloid Leukemia With Chidamide, Fludarabine, Cytarabine and Granulocyte-Colony Stimulating Factor With Subsequent Bridging to Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation: Treating Relapsed Refractory Acute Myeloid Leukemia With Chidamide, Fludarabine, Cytarabine and G-CSF. Mediterr J Hematol Infect Dis 2022, 14 (1), e2022025. https://doi.org/10.4084/MJHID.2022.025.